Contrast-enhanced magnetic resonance imaging with a novel nano-size contrast agent for the clinical diagnosis of patients with lung cancer.

about

Contrast-enhanced magnetic resonance imaging with a novel nano-size contrast agent for the clinical diagnosis of patients with lung cancer.

Item

http://www.wikidata.org/entity/Q55072826

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Contrast-enhanced magnetic res ...... of patients with lung cancer.

@en

Contrast-enhanced magnetic res ...... of patients with lung cancer.

@nl

type

Item

label

Contrast-enhanced magnetic res ...... of patients with lung cancer.

@en

Contrast-enhanced magnetic res ...... of patients with lung cancer.

@nl

prefLabel

Contrast-enhanced magnetic res ...... of patients with lung cancer.

@en

Contrast-enhanced magnetic res ...... of patients with lung cancer.

@nl

P1476

Contrast-enhanced magnetic res ...... s of patients with lung cancer

@en

P2093

Bin Zhao

http://www.w3.org/2001/XMLSchema#string

Jianwei Gao

http://www.w3.org/2001/XMLSchema#string

Lei Li

http://www.w3.org/2001/XMLSchema#string

Rui Guo

http://www.w3.org/2001/XMLSchema#string

Xia Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Computer modeling of lung cancer diagnosis-to-treatment process

Lung cancer diagnosis and staging in the minimally invasive age with increasing demands for tissue analysis

The Role of PET/CT Molecular Imaging in the Diagnosis of Recurrence and Surveillance of Patients Treated for Non-Small Cell Lung Cancer

Resistance mechanisms after tyrosine kinase inhibitors afatinib and crizotinib in non-small cell lung cancer, a review of the literature

Computed tomography imaging of primary lung cancer in mice using a liposomal-iodinated contrast agent

Double labeling and comparison of fluorescence intensity and photostability between quantum dots and FITC in oral tumors.

Epidermal growth factor receptor-targeted ultra-small superparamagnetic iron oxide particles for magnetic resonance molecular imaging of lung cancer cells in vitro.

Overall response rate, progression-free survival, and overall survival with targeted and standard therapies in advanced non-small-cell lung cancer: US Food and Drug Administration trial-level and patient-level analyses.

Case report of a patient with left ventricular assistance device undergoing chemotherapy for a new diagnosis of lung cancer

Validity of breast, lung and colorectal cancer diagnoses in administrative databases: a systematic review protocol.

P304

5415-5421

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2018.6112

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29904421

http://www.w3.org/2001/XMLSchema#string

P932

5996680

http://www.w3.org/2001/XMLSchema#string